WA AND QLD RSV IMMUNISATION PROGRAMS SHOW SIGNIFICANT REDUCTION IN INFANT HOSPITALISATIONS Consumer and HCP awareness, advocacy focus until national program decision is reversed
Filmed Perth, Western Australia | October 2024
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
Associate Professor Hannah Moore OAM, Program Head of Infections and Vaccines at the Kids Research Institute Australia, met with Australian Health Journal to discuss the impact of Respiratory Syncytial Virus (RSV) on children and immunisation showing evidence of a significant reduction in hospitalisations.
She talks about RSV causing chest infections in babies and adults, with most children being infected by the age of three. However, certain groups face higher disease rates, and infants under six months are particularly vulnerable, with up to one in 30 being hospitalised. Even older children up to five years old experience hospitalisation rates for RSV around one in 500 children.
Australian Health Journal also spoke with Catherine Hughes, the Founder and Executive Director of the Immunisation Foundation of Australia (IFA), on the need for RSV immunisations to be included in the National Immunisation Plan to ensure equitable access for vulnerable Australians. RSV immunisation programs in Western Australia and Queensland are showing promising results, leading to a significant reduction in hospitalisations. This is in contrast with the disappointment in the PBAC recently rejecting a national RSV vaccine push.
“Australia urgently needs a nationwide RSV immunisation program,” said Catherine Hughes AM, Founder and Director of the Immunisation Foundation of Australia.
IFA aims to raise awareness of RSV severity and has launched the “Unite Against RSV” campaign to provide resources for the clinical community and families. Additionally, vaccines for adults over 60 and pregnant women, as well as antibody therapy for infants, have been approved to combat RSV. The Foundation also provides regular updates on policy changes related to RSV to clinicians and other providers through its website and email subscriptions.
Efforts are being made to ensure that all Australians, especially vulnerable individuals, have access to affordable RSV immunisations. The Foundation’s advocacy work aims to include RSV immunisations on the National Immunisation Plan to guarantee easy access for all Australian families. The success of RSV immunisation programs in Western Australia and Queensland mounts the evidence on the positive impact of proactive measures in combating RSV.
-
Australian Teletrial Program reaches significant milestones in trials and participants
Launched in 2022, the Australian Teletrial Program is an initiative designed to improve access to clinical trials for people living in regional and remote areas of Australia. It uses telemedicine and digital technologies to enable patients to participate in clinical trials without needing to travel long distances to major metropolitan centres, which can often be a barrier to participation for those in rural and isolated locations.
Recently Australian Health Journal met with Kaye Hewson, Director, Australian Teletrials Program, who spoke about the program’s recent achievements.
-
Inaugural report into Australasian Paramedicine Workforce Survey report to aid workforce planning
In a milestone for paramedicine, the Australasian College of Paramedicine earlier this year released the first report of a landmark three-year study identifying and exploring trends that affect the Australasian paramedicine workforce.
The inaugural Australasian Paramedicine Workforce Survey report 2023-24 explores the demographic, career trajectory, work motivations and conditions for those working in clinical, management and educational capacities within the paramedicine workforce of Australia and Aotearoa New Zealand. -
Connected Health Systems
Challenges in health care delivery have compounded, with clinical staff being exposed to the Omicron COVID variant. Reduced staffing has brought on its challenges to most already-strained state health care systems and the people working in them.
However, over the past 2 years of the pandemic, technology has played an increasing role on the front end for patients and consumers at home and clinicians in the medical setting. Much more is planned in technology that will deliver efficiency, reduce risk and make available new models of care. This has the potential to touch the working lives of all stakeholders and recipients of care.
